“…Considerable effort is being invested in porous protein crystals, which possess large well-defined pores that permit the uptake and release of substrate/product cargo, enabling, for example, controlled drug delivery. Such ''frameworks'', with solvent contents 450%, can be achieved by using naturally porous cage proteins such as ferritin 3,4 and viral capsids, 5,6 or by engineered protein assembly with inducers that direct the formation of porous structures. [7][8][9][10][11][12] Among the assembly inducing strategies, metal ions/complexes 3,9 and organic ligands 7,8,10,11 are being used to noncovalently crosslink proteins.…”